Institutional Career Development Core

机构职业发展核心

基本信息

批准号：
10363703
负责人：
David H Ingbar
金额：
$ 119.83万
依托单位：
UNIVERSITY OF MINNESOTA
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-03-30 至 2024-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10363703
关键词：
Active Learning Applications Grants Appointment Award Biomedical Engineering Cities Clinical Research Clinical Sciences Communication Communities Competence County Dentistry Development Development Plans Ensure Environment Ethics Faculty Faculty Recruitment Fostering Foundations Funding Future Generations Goals Grant Health Hospitals Individual Informatics Institutes Institution Investigation K-Series Research Career Programs Leadership Medical center Medicine Mentors Minnesota NCI Scholars Program National Center for Advancing Translational Sciences Nursery Schools Patient Care Pharmacy facility Positioning Attribute Principal Investigator Program Development Public Health Public Health Nursing Research Research Institute Research Personnel Schools Science Series Talents Time Training Training Programs Translational Research Twin Multiple Birth United States National Institutes of Health Universities Veterinary Medicine Visit Wages base career career development college community engagement design education research experience improved innovation medical schools multidisciplinary programs responsible research conduct skills success translational research program translational scientist undergraduate student

项目摘要

UMN CTSI is ideally positioned to implement and train translational discovery teams comprised of multidisciplinary researchers from the 6 schools and colleges of the University’s Academic Health Center (Medicine, Public Health, Nursing, Pharmacy, Dentistry, Veterinary Medicine), institutes and centers in the broader University, and 2 major hospitals in the Twin Cities – the Minneapolis VA Medical Center and the Hennepin County Medical Center – that currently partner with KL2 researchers. We will 1) Provide rigorous, competency-based training in the design and conduct of high-quality clinical and translational research with both required and individualized components; 2) Ensure KL2 Scholars acquire skills and experience in team science, communication, responsible conduct of research, and community and stakeholder engagement; 3) Promote career development activities of KL2 Scholars, including training them as mentors and leaders, and offering experiential learning opportunities; and 4) Use multidisciplinary mentoring to support KL2 Scholar development of a productive clinical and translational research program, resulting in successful grant applications and transition to independent investigations. We will accomplish this in part by key innovations that build upon our highly successful KL2 program: 1. Continue 3 full years of KL2 Scholar training; 2. Optimize Scholar success by extending some career development support beyond 3 years; 3. Expand mentor training and develop new shareable components of mentor training, including institution of a Leadership in Team Science training program; 4. Use individualized development plans to tailor training and meet NCATS competencies; 5. Augment community engagement with community stakeholder liaisons for each Scholar; 6. Dedicate training in communication and leadership skills essential for career success; 7. Initiate Translational Research Retreats with focused training in team science, ethics, and informatics; 8. Increase Scholar involvement with biomedical engineering and experiential opportunities; 9. Revitalize educational opportunities in informatics and responsible conduct of research; 10. Broaden the CTSI-Ed leadership team for expanded career development training; 11. Begin new initiatives that promote individual K- award and R- award submission; and 12. Increase the diversity of the K- Scholar group and improve the pipeline of underrepresented in medicine scholars with a new CTSI Pre-K Discovery Scholars program, new two-day Visiting Professorships held 3 times per year, and new School of Medicine guaranteed and fully financed (salary; start-up funds) trainee-to-faculty appointment and faculty recruitment diversity plan. Impact. With these innovations and activities in place and robust institutional support, we expect that our KL2 Scholars will become highly talented leaders in their field, capable of disseminating their research and expertise through multiple channels, contributing to multidisciplinary investigations, and mentoring other researchers.

UMN CTSI 非常适合实施和培训由以下人员组成的转化发现团队：来自大学学术健康中心6个学院的多学科研究人员（医学、公共卫生、护理、药学、牙科、兽医）、机构和中心更广泛的大学，以及双子城的 2 家主要医院 - 明尼阿波利斯退伍军人医疗中心和亨内平县医疗中心 – 目前与 KL2 研究人员合作，我们将 1) 提供严格的、设计和进行高质量临床和转化研究的基于能力的培训 2) 确保KL2学者获得团队技能和经验科学、沟通、负责任的研究行为以及社区和利益相关者的参与；3) 促进 KL2 学者的职业发展活动，包括将他们培训为导师和领导者，以及提供体验式学习机会；以及 4) 利用多学科指导来支持 KL2 学者开发富有成效的临床和转化研究计划，并获得成功的资助我们将通过关键创新来部分实现这一目标。以我们非常成功的 KL2 计划为基础： 1. 继续 3 年的 KL2 学者培训；通过延长 3 年以上的职业发展支持来优化学者的成功； 3. 扩大导师范围；培训并开发导师培训的新的可共享部分，包括建立领导力团队科学培训计划；4.使用个性化发展计划来定制培训并满足NCATS 能力； 5. 通过每位学者的社区利益相关者联络来增强社区参与；专门培训对职业成功至关重要的沟通和领导技能； 8. 研究静修，重点培训团队科学、道德和信息学；参与生物医学工程和体验机会； 9. 重振教育机会； 10. 扩大 CTSI-Ed 领导团队以扩大规模 11. 开展个人K-奖和R-奖的新举措 12. 增加K-学者群体的多样性并改善研究渠道医学学者中代表性不足的新 CTSI Pre-K Discovery Scholars 计划、新的为期两天的计划每年举办3次客座教授职位，新医学院得到保证和全额资助（工资；启动资金）实习生到教师的任命和教师招聘多样性计划。这些创新和活动到位以及强有力的机构支持，我们希望我们的 KL2 学者能够成为所在领域才华横溢的领导者，能够通过以下方式传播他们的研究和专业知识多种渠道，促进多学科研究，并指导其他研究人员。

项目成果

期刊论文数量（69）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Clinical Decision Support Intervention for Rib Fracture Treatment.

DOI：
10.1016/j.jamcollsurg.2020.04.023
发表时间：
2020-08
期刊：
Journal of the American College of Surgeons
影响因子：
5.2
作者：
Macheel C;Reicks P;Sybrant C;Evans C;Farhat J;West MA;Tignanelli CJ
通讯作者：
Tignanelli CJ

Determining Electrode Placement for Transcranial Direct Current Stimulation: A Comparison of EEG- Versus TMS-Guided Methods.

确定经颅直流电刺激的电极放置：脑电图与 TMS 引导方法的比较。

DOI：
10.1177/1550059417709177
发表时间：
2017
期刊：
Clinical EEG and neuroscience
影响因子：
2
作者：
Rich,TonyaL;Menk,JeremiahS;Rudser,KyleD;Chen,Mo;Meekins,GreggD;Peña,Edgar;Feyma,Timothy;Bawroski,Kay;Bush,Christina;Gillick,BernadetteT
通讯作者：
Gillick,BernadetteT

Responding to COVID-19 Through Interhospital Resource Coordination: A Mixed-Methods Evaluation.

DOI：
10.1097/pts.0000000000000916
发表时间：
2022-06-01
期刊：
Journal of patient safety
影响因子：
2.2
作者：
Usher MG;Tignanelli CJ;Hilliard B;Kaltenborn ZP;Lupei MI;Simon G;Shah S;Kirsch JD;Melton GB;Ingraham NE;Olson APJ;Baum KD
通讯作者：
Baum KD

Who Is Most Burdened in Health Care? An Analysis of Responses to the ICAN Discussion Aid.

谁在医疗保健方面负担最重？

DOI：
10.3122/jabfm.2022.220251r1
发表时间：
2023
期刊：
Journal of the American Board of Family Medicine : JABFM
影响因子：
0
作者：
Steiger,KyleG;Boehmer,KaseyR;Klanderman,MollyC;Mookadam,Aamena;Koneru,SethuSandeep;Montori,VictorM;Mookadam,Martina
通讯作者：
Mookadam,Martina

Viral Shedding in Mice following Intravenous Adenovirus Injection: Impact on Biosafety Classification.